Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Fosbretabulin (Primary)
- Indications Choroidal neovascularisation
- Focus Therapeutic Use
- Sponsors Mateon Therapeutics; OXiGENE
- 12 Apr 2014 New trial record